• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Molecular Assays for Quantitative and Qualitative Detection of Influenza Virus and Oseltamivir Resistance Mutations

tetano

Editor, Senior Moderator
J Mol Diagn. 2013 Apr 8. pii: S1525-1578(13)00030-5. doi: 10.1016/j.jmoldx.2012.11.007. [Epub ahead of print]
Molecular Assays for Quantitative and Qualitative Detection of Influenza Virus and Oseltamivir Resistance Mutations.
van der Vries E, Anber J, van der Linden A, Wu Y, Maaskant J, Stadhouders R, van Beek R, Rimmelzwaan G, Osterhaus A, Boucher C, Schutten M.
Source

Department of Virology, Erasmus MC, Rotterdam, The Netherlands.
Abstract

Sensitive and reproducible molecular assays are essential for influenza virus diagnostics. This manuscript describes the design, validation, and evaluation of a set of real-time RT-PCR assays for quantification and subtyping of human influenza viruses from patient respiratory material. Four assays are included for detection of oseltamivir resistance mutations H275Y in prepandemic and pandemic influenza A/H1N1 and E119V and R292K in influenza A/H3N2 neuraminidase. The lower limits of detection of the quantification assay were determined to be 1.7 log10 virus particles per milliliter (vp/mL) for influenza A and 2.2 log10 vp/mL for influenza B virus. The lower limits of quantification were 2.1 and 2.3 log10 vp/mL, respectively. The RT-PCR efficiencies and lower limits of detection of the quantification assays were only marginally affected when tested on the most dissimilar target sequences found in the GenBank database. Finally, the resistance RT-PCR assays detected at least 5% mutant viruses present in mixtures containing both wild-type and mutant viruses with approximated limits of detection of 2.4 log10 vp/mL. Overall, this set of RT-PCR assays is a powerful tool for enhanced influenza virus surveillance.

Copyright ? 2013 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

PMID:
23597879
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23597879
 
Back
Top Bottom